[
  {
    "question": "What is least medication to interact with OCP:",
    "option_a": "Keppra",
    "option_b": "Lamictal",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "This question tests the understanding of drug interactions between antiepileptic medications and oral contraceptive pills (OCPs). Some antiepileptic drugs induce hepatic enzymes, altering the metabolism of steroid hormones, while others do not. Levetiracetam (Keppra) is known for its minimal effect on cytochrome P450 enzymes and thus is least likely to interact with OCPs. Many antiepileptics, such as lamotrigine and older drugs (phenytoin, carbamazepine), can induce or inhibit hepatic enzymes. Enzyme induction leads to increased metabolism of estrogen and progestin, reducing contraceptive efficacy. Levetiracetam is primarily renally excreted and does not induce hepatic enzymes, so it does not affect OCP metabolism. For women of childbearing age with epilepsy, choosing an antiepileptic that does not compromise the efficacy of OCPs is crucial to prevent unintended pregnancies. Levetiracetam is commonly preferred in such settings because it avoids these pharmacokinetic interactions. In the context of drug interactions, clinicians review a patient\u2019s medication list and check for known enzyme inducers. Laboratory measurements of drug levels are sometimes useful if interactions are suspected, but understanding the metabolic pathways is key. For women using OCPs, first-line management involves using antiepileptics that do not interact with hormonal contraception. Levetiracetam is preferred. If lamotrigine is used, one may need to adjust the dose or consider alternative contraceptive methods. Pregnancy and lactation considerations include using drugs with proven safety profiles in these populations \u2013 levetiracetam has reassuring data in pregnancy compared to enzyme-inducing alternatives. Option A (Keppra) is correct because it is not a hepatic enzyme inducer and therefore has minimal interaction with OCPs. Option B (Lamictal) can interact with OCPs; estrogen can increase lamotrigine clearance, thereby lowering its plasma levels and potentially reducing its efficacy. 1. Always be mindful of enzyme induction when prescribing antiepileptics in women of reproductive age. 2. Levetiracetam, given its renal clearance and minimal interaction profile, is an advantageous choice. 3. Lamotrigine levels may drop with concurrent OCP use, necessitating monitoring or dosage adjustments. Recent guidelines and studies stress the importance of evaluating drug\u2013drug interactions in women of childbearing potential. Updated epilepsy management guidelines favor non-enzyme inducing agents like levetiracetam when concomitant OCP use is planned.",
    "exam_year": "2022",
    "exam_type": "Promotion"
  },
  {
    "question": "Same above question but they ask about what is EEG finding?",
    "option_a": "Burst suppression",
    "option_b": "NCSE",
    "option_c": "Not remember others but EEG was NCSE",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Epilepsy",
    "explanation": "This question focuses on recognizing electroencephalogram (EEG) patterns typically associated with specific seizure conditions. Nonconvulsive status epilepticus (NCSE) is an important clinical-electrodiagnostic entity where prolonged epileptic activity occurs without overt convulsions. NCSE is characterized by continuous or near-continuous epileptiform discharges that compromise consciousness without producing major motor signs. The lack of convulsions makes clinical diagnosis challenging without EEG confirmation. Patients presenting with altered mental status, confusion, or subtle behavioral changes may be experiencing NCSE. In such cases, the EEG is crucial to detect the persistent epileptiform activity that underlies the condition. The differential diagnosis for altered mental status includes metabolic encephalopathy, drug intoxication, and other nonconvulsive seizures. EEG is the definitive test to distinguish NCSE from these conditions by showing continuous epileptic activity. Management of NCSE begins with intravenous benzodiazepines (first-line), followed by loading doses of antiepileptic drugs like levetiracetam, valproate, or fosphenytoin. In pregnancy or lactation, benzodiazepines (e.g., lorazepam) are considered relatively safe in acute settings, but long\u2010term therapy should be tailored to minimize fetal exposure. Option A (Burst suppression) is typically seen during barbiturate-induced coma for refractory status epilepticus rather than in NCSE. Option B, identifying NCSE, correctly matches the presumed EEG pattern in the clinical scenario. Option C is not clearly defined but the marked answer, NCSE, appropriately reflects the EEG findings in this context. 1. Consider NCSE in patients with unexplained altered mental status and subtle clinical signs. 2. Prompt EEG evaluation is critical for the diagnosis of NCSE. 3. Treatment should not be delayed as NCSE can lead to significant morbidity. Recent research emphasizes early detection of NCSE with continuous EEG monitoring in high-risk patients. Updated guidelines advocate for rapid EEG assessment and early treatment with benzodiazepines to improve outcomes.",
    "exam_year": "2023",
    "exam_type": "Promotion"
  },
  {
    "question": "A young lady S/P tumor resection presented with a staring spell with loss of awareness is the seizure classification. EEG shoewd frontal discharges focal",
    "option_a": "(Focal motor onset with impaired awareness) is incorrect because the clinical description lacked motor phenomena. Option B (Absence seizure) is incorrect as typical absence seizures are generalized with a hallmark 3 Hz spike",
    "option_b": "",
    "option_c": "(Unknown onset) is incorrect since the EEG clearly indicates focal frontal activity. Option D (Focal non",
    "option_d": "",
    "option_e": "",
    "correct_answer": "D",
    "subspecialty": "Epilepsy",
    "explanation": "This question evaluates knowledge of ILAE seizure classification. The focus is on differentiating focal seizures with or without motor onset and distinguishing them from generalized seizures, based on both clinical presentation (staring spell, loss of awareness) and EEG findings (frontal discharges). Focal seizures originate from a localized area in the brain, such as the frontal lobe. When these seizures are non-motor, they may present with behavioral arrest or staring spells and an impaired awareness, reflecting localized dysfunction without overt convulsive activity. A young lady post-tumor resection presenting with a staring spell and loss of awareness suggests a focal seizure rather than a generalized absence seizure. The EEG showing focal frontal discharges supports the diagnosis of a focal seizure rather than a generalized one. Differential diagnoses include absence seizures (which are typically brief, generalized, and seen in childhood with 3 Hz spike-and-wave activity), focal motor seizures (which include motor phenomena), and seizures of unknown onset. The presence of focal EEG abnormalities pinpoints the seizure as of focal origin. Management of focal seizures involves appropriate antiepileptic drugs such as levetiracetam, lamotrigine, or lacosamide. In post-surgical patients, careful titration and monitoring are needed. In pregnant patients, medications like lamotrigine and levetiracetam are preferred due to favorable safety profiles. Option A (Focal motor onset with impaired awareness) is incorrect because the clinical description lacked motor phenomena. Option B (Absence seizure) is incorrect as typical absence seizures are generalized with a hallmark 3 Hz spike-and-wave pattern and are more common in children. Option C (Unknown onset) is incorrect since the EEG clearly indicates focal frontal activity. Option D (Focal non-motor onset with impaired awareness) correctly describes the clinical presentation and EEG findings, making it the correct answer. 1. Focal non-motor seizures can present subtly, often as staring spells with impaired awareness. 2. EEG localization is key in distinguishing focal seizures from generalized epilepsy. 3. Post-surgical patients with seizures require thorough evaluation to correlate clinical events with EEG findings. Recent updates in the ILAE classification emphasize the importance of correlating clinical semiology with EEG data, especially in cases with atypical manifestations such as post-surgical seizures. Current guidelines support the tailored use of antiepileptic drugs based on seizure type and individual patient factors.",
    "exam_year": "2023",
    "exam_type": "Promotion"
  },
  {
    "question": "Male with early morning seizures and EEG of jme treatment",
    "option_a": "(Keppra) is considered correct in this scenario as it effectively manages myoclonic and generalized seizures in JME, with a favorable safety profile and minimal drug interactions. Option B (Depakin/Valproate) is also effective and historically the gold standard in JME but is less favored in women; since the patient is male, either could be chosen, but the exam\u2019s option analysis supports Keppra as the marked answer. Option C (Carbamazepine) is inappropriate because it may worsen generalized seizures. Option D (Ethosuximide) is suitable only for absence seizures and not for the myoclonic or generalized tonic",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "a",
    "subspecialty": "Epilepsy",
    "explanation": "This question addresses the treatment of Juvenile Myoclonic Epilepsy (JME), an idiopathic generalized epilepsy syndrome often characterized by early morning seizures, including myoclonic jerks and generalized tonic-clonic seizures. JME is believed to involve altered thalamocortical network excitability leading to abnormal, generalized epileptiform discharges on EEG. Early morning seizures occur due to circadian influences and sleep-related factors. Patients with JME typically present during adolescence or early adulthood with myoclonic jerks, especially shortly after waking. The EEG in JME commonly demonstrates generalized spike-and-wave discharges. Appropriate treatment must address both myoclonic and generalized tonic-clonic seizures. Diagnosis is based on clinical history and confirmation with an EEG showing generalized discharges. Differential diagnoses include other forms of generalized epilepsy and myoclonic disorders, but the characteristic early morning pattern helps in distinguishing JME. First-line treatment options for JME include valproate and levetiracetam. In male patients, while valproate is highly effective (often considered the gold standard), levetiracetam (Keppra) is also widely used given its efficacy and favorable side effect profile. In pregnancy and lactation, valproate is generally avoided in women of childbearing potential due to teratogenic risk, making levetiracetam a preferred alternative; however, in males, both are acceptable options. Option A (Keppra) is considered correct in this scenario as it effectively manages myoclonic and generalized seizures in JME, with a favorable safety profile and minimal drug interactions. Option B (Depakin/Valproate) is also effective and historically the gold standard in JME but is less favored in women; since the patient is male, either could be chosen, but the exam\u2019s option analysis supports Keppra as the marked answer. Option C (Carbamazepine) is inappropriate because it may worsen generalized seizures. Option D (Ethosuximide) is suitable only for absence seizures and not for the myoclonic or generalized tonic-clonic components of JME. 1. Early morning myoclonic jerks are a hallmark of JME. 2. Both valproate and levetiracetam are effective, but levetiracetam is often preferred in populations vulnerable to valproate\u2019s teratogenic effects. 3. Avoid using medications like carbamazepine that can exacerbate generalized epilepsies. Recent guidelines confirm that while valproate remains a highly effective option for JME, levetiracetam\u2019s efficacy and safety profile have made it an increasingly popular first-line treatment\u2014especially for patients for whom teratogenicity is a concern. Current research supports individualized treatment strategies based on patient demographics and specific seizure profiles.",
    "exam_year": "2023",
    "exam_type": "Promotion"
  },
  {
    "question": "Same stem pt on sedation with EEG findings [idk.. kinda bilateral generalized slike and wave]. What to do?",
    "option_a": "Stop sedation",
    "option_b": "Load phenytoin 15-20mg/kg",
    "option_c": "Continue sedation",
    "option_d": "Start levetiracetam",
    "option_e": "Do brain death assessment",
    "correct_answer": "C",
    "subspecialty": "Epilepsy",
    "explanation": "In the intensive care setting, patients on sedation often have EEG patterns that may mimic epileptiform activity. It is essential to distinguish sedation\u2010related changes from true ictal (seizure) activity. Continuous EEG is used to monitor these patients, and interpretation must always take into account the level of sedation and clinical exam. Sedative agents (such as propofol, midazolam, etc.) alter neuronal activity, producing slowing, periodic discharges, or even burst suppression patterns on EEG. These changes can sometimes resemble generalized spike-and-wave discharges. In contrast, true nonconvulsive status epilepticus is related to uncontrolled neuronal firing due to an underlying epileptogenic process. The current evidence emphasizes that many EEG patterns seen in sedated patients are a reflection of drug effects rather than epileptic activity. When a sedated patient shows bilateral generalized spike\u2010like wave discharges on EEG, it is important to correlate these findings with clinical signs. If there are no clinical indicators of seizure activity (such as subtle motor movements or hemodynamic instability), these EEG findings may simply be a drug effect. A careful sedation \u201choliday\u201d or adjustment can help differentiate true seizures from sedation-induced changes. Differential diagnoses include nonconvulsive status epilepticus versus sedation-induced EEG abnormalities. The clinician should verify the depth of sedation \u2013 sometimes a temporary reduction in sedative dosing (if clinically safe) is used to see if the EEG normalizes. Other causes for generalized periodic discharges (e.g., metabolic encephalopathy) should also be considered by a thorough clinical evaluation and blood work. Current guidelines recommend that before escalating to additional antiepileptic drugs (AEDs), the clinician should assess whether the observed EEG changes truly reflect ictal activity. A tiered approach is recommended: \u2022 First Line \u2013 Reassess sedation levels, consider a sedation holiday if safe, and correlate with clinical exam. \u2022 Second Line \u2013 If after sedation adjustment the pattern persists with clinical or electrographic evidence of nonconvulsive seizures, then loading with a fast\u2010acting AED (or increasing sedative dose to reach a burst\u2010suppression target) may be indicated. Pregnancy and lactation considerations are less applicable in the ICU sedation scenario, but when AEDs are used in pregnant patients, agents with lower teratogenic potential and therapeutic drug monitoring are recommended. Option A (Stop sedation) might be too abrupt if the patient requires sedation for other reasons. Option B (Load phenytoin) is not warranted unless there is clear evidence of nonconvulsive status epilepticus \u2013 which, in an adequately sedated patient with nonspecific EEG changes, is unlikely. Option C (Continue sedation) is the most appropriate if the EEG changes are consistent with sedation effects rather than ictal activity. Option D (Start levetiracetam) is another AED option but, like phenytoin, should not be initiated without clear evidence of seizure activity. Option E (Do brain death assessment) is not pertinent in this context. \u2022 Always correlate EEG findings with the clinical state, especially in sedated patients. \u2022 A sedation holiday (when safe) is a key step in distinguishing drug\u2010induced EEG changes from true seizures. \u2022 Avoid unnecessary loading of AEDs when the EEG pattern may be due to sedation. Recent literature and consensus guidelines emphasize the importance of continuous EEG monitoring and careful interpretation in the ICU. Studies have shown that sedation\u2010induced EEG patterns, while sometimes alarming in appearance, do not always indicate active seizure activity. This has led to recommendations to avoid premature escalation of AED therapy based solely on EEG findings.",
    "exam_year": "2023",
    "exam_type": "Promotion"
  },
  {
    "question": "Female with abnormal movement inform of arching back EEG attached was normal during event",
    "option_a": "psychogenic",
    "option_b": "TLE",
    "option_c": "HSV",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Psychogenic non-epileptic seizures (PNES) are episodes that resemble epileptic seizures but are not due to abnormal electrical discharges in the brain. They are classified as a conversion disorder and have a psychological origin. PNES are believed to result from underlying psychological distress or psychiatric conditions. Unlike epileptic seizures, there is no abnormal neuronal firing; rather, the abnormal motor manifestations are psychosomatic. Because they are not due to true epileptiform activity, EEG recordings are typically normal during these events. In the presented case, the female patient displays an abnormal movement such as arching of the back. The normal EEG during the event strongly supports a diagnosis of PNES rather than an epileptic seizure. This presentation is common in PNES, where the physical manifestations can be dramatic but without corresponding electrical changes on EEG. The main differential diagnosis is an epileptic seizure, particularly from temporal lobe epilepsy. Video EEG monitoring is the gold standard for differentiating PNES from epileptic activity. Additional diagnostic work-up may include psychiatric evaluation to identify underlying stressors or emotional conflict. The management of PNES involves a multidisciplinary approach. First-line treatment includes psychological therapies such as cognitive behavioral therapy (CBT) and other forms of psychotherapy, along with psychoeducation. It is important to avoid unnecessary AED treatment, which is ineffective in PNES. In pregnancy and lactation, avoiding unnecessary exposure to AEDs is especially crucial due to teratogenic risks. Supportive and psychiatric interventions are the mainstay of management. Option A (psychogenic) is correct, as the diagnosis of PNES is supported by the normal EEG during the abnormal movements. Option B (TLE) and Option C (HSV encephalitis) would typically show EEG abnormalities or other clinical signs, and are less consistent with a normal EEG during the episode. \u2022 PNES typically present with dramatic, often stereotyped movements but with normal EEGs during events. \u2022 Video EEG monitoring is key in differentiating PNES from epileptic seizures. \u2022 Avoid unnecessary AED use in patients with PNES, as it does not address the underlying psychological cause. Recent research stresses the importance of early and accurate identification of PNES to prevent misdiagnosis and unneeded treatment with antiepileptic drugs. Updated guidelines favor a multidisciplinary assessment, including psychiatric evaluation and psychotherapy, to optimize outcomes in PNES.",
    "exam_year": "2023",
    "exam_type": "Promotion"
  },
  {
    "question": "pt with aura of fear and seizure localization",
    "option_a": "Temporal",
    "option_b": "Insular lobe in temporal",
    "option_c": "Cingulate ala?",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Auras are subjective sensations that precede seizures, and an aura of fear is classically associated with seizure onset in regions of the brain involved in emotion, most notably the mesial temporal lobe (including the amygdala). Seizures arising in the mesial temporal structures, particularly the amygdala, can produce intense fear or 'dread' as an aura. This is due to the role of these structures in emotion processing. Abnormal electrical discharge in this region leads to the subjective experience of fear. A patient reporting an aura of fear is most typically experiencing a focal onset seizure from the temporal lobe. While other areas (such as the insula or cingulate cortex) can sometimes be involved, the temporal lobe is by far the most common site for such manifestations. The workup includes a detailed history, video-EEG monitoring, and neuroimaging (usually MRI) to help localize the seizure focus. Differential diagnoses include insular seizures or even frontal lobe seizures; however, the specific quality of a fear aura strongly suggests a temporal lobe onset. Management includes first-line treatment with antiepileptic drugs (AEDs) such as levetiracetam, lamotrigine, or carbamazepine. In patients of childbearing age or those who are pregnant/lactating, medication selection should take into account teratogenic risks and be chosen after careful counseling and monitoring per current guidelines (e.g., folic acid supplementation). In refractory cases, surgical evaluation may be considered. Option A (Temporal) is correct because a fear aura is most strongly associated with temporal lobe epilepsy. Option B (Insular lobe in temporal) and Option C (Cingulate, ala) are less typical for an isolated fear aura and are not as strongly supported by the clinical presentation. \u2022 A fear aura is classically linked to mesial temporal lobe involvement, especially the amygdala. \u2022 Detailed patient history and video EEG are key in localizing the seizure focus. \u2022 Temporal lobe epilepsy is the most frequently encountered form of focal epilepsy. Recent advances in neuroimaging and continuous EEG monitoring have reinforced the role of the mesial temporal structures in generating fear auras. Updated guidelines highlight the importance of precise seizure localization for management and potential surgical intervention.",
    "exam_year": "2023",
    "exam_type": "Promotion"
  },
  {
    "question": "Pt on CBZ for long time for focal epilepsy. Recently added VPA for him. What would change?",
    "option_a": "inc CBZ epoxide level",
    "option_b": "Inc risk of hyponatremia",
    "option_c": "dec CBZ level",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "When managing epilepsy, understanding drug interactions between antiepileptic medications is crucial. Carbamazepine (CBZ) is a commonly used AED for focal seizures, and its metabolism can be altered by the addition of valproic acid (VPA). Carbamazepine is metabolized to its active metabolite, carbamazepine-10,11-epoxide, which is normally further metabolized by epoxide hydrolase. VPA is known to inhibit epoxide hydrolase, leading to an accumulation of CBZ-epoxide. This metabolite is pharmacologically active and potentially toxic, which can result in enhanced side effects even if CBZ levels themselves remain unchanged. The increase in CBZ-epoxide levels can contribute to an increased risk of toxicity (e.g., diplopia, ataxia, gastrointestinal disturbances) even in patients who appear to have therapeutic CBZ concentrations. It is important to recognize this interaction when modifying antiepileptic regimens, as patients may develop adverse effects that mimic seizure exacerbation. When a patient on CBZ is started on VPA, serial monitoring of drug levels (including the active metabolite, when available) and clinical evaluation for signs of toxicity is recommended. Differential considerations include side effects from each drug independently, but the key is recognizing the interaction effect. When VPA is added to an ongoing CBZ regimen, dosages may need to be adjusted to minimize toxicity. First-line management includes careful therapeutic drug monitoring and patient education regarding signs of toxicity. In pregnant and lactating patients, special consideration is required because both drugs have potential teratogenic effects; VPA in particular is known for its high teratogenic risk, so clinicians must balance seizure control with fetal risk, often opting for lower doses and close monitoring along with folic acid supplementation. Option A (increased CBZ epoxide level) is correct because VPA inhibits the enzyme responsible for metabolizing the CBZ epoxide, leading to its accumulation. Option B (increased risk of hyponatremia) is less directly related to the addition of VPA; hyponatremia is more typically a side effect of CBZ alone. Option C (decreased CBZ level) is not consistent with the known interaction mechanism. \u2022 VPA inhibits epoxide hydrolase, leading to higher levels of the active CBZ metabolite even if total CBZ levels remain stable. \u2022 Monitor for signs of CBZ toxicity in patients on combination therapy. \u2022 In women of childbearing potential, consider the teratogenic risk of VPA and use the lowest effective dose with appropriate counseling. Recent guidelines and studies reiterate the importance of anticipating and monitoring for antiepileptic drug interactions. Enhanced awareness of the CBZ-VPA interaction has led to improved patient safety through dose adjustments and close therapeutic drug monitoring, particularly in vulnerable populations like pregnant women.",
    "exam_year": "2023",
    "exam_type": "Promotion"
  },
  {
    "question": "28 y/o female, with hemorrhagic lesion in brain, had staring episode with post-event confusion. Which of the following is a suitable ASM:",
    "option_a": "Valproic acid",
    "option_b": "Ethosuximide",
    "option_c": "Keppra",
    "option_d": "Topiramate",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Epilepsy",
    "explanation": "In patients with structural brain lesions such as a hemorrhage, seizures often arise due to local cortical irritation. The antiseizure medication (ASM) chosen needs to be effective for focal seizures, have a rapid onset of action, a favorable side effect profile, and fewer interactions. Keppra (Levetiracetam) meets these criteria and is widely used in this setting. The hemorrhagic lesion triggers an epileptogenic focus by irritating adjacent neuronal tissue. This disruption in local neural networks causes hyperexcitability, resulting in focal seizures that can present with impaired awareness, such as a 'staring episode' followed by postictal confusion. Levetiracetam modulates synaptic neurotransmitter release through binding to the synaptic vesicle protein 2A, thereby stabilizing neuronal excitability. A 28-year-old female with a hemorrhagic brain lesion experiencing a staring episode with post-event confusion likely had a focal seizure with impaired awareness. In this demographic, careful choice of ASM is critical to prevent recurrent seizures and to avoid medications with high teratogenic potential, given her reproductive age. The diagnostic workup includes neuroimaging (CT/MRI) to assess the hemorrhagic lesion, along with EEG monitoring to characterize the epileptiform activity. Differential diagnoses include syncope, transient ischemic attacks, psychogenic nonepileptic seizures, and migraine auras. These conditions are differentiated by correlating clinical features, imaging findings, and EEG results. The management of seizures secondary to hemorrhagic lesions involves controlling the acute seizure activity and addressing the underlying lesion. First-line treatment with Levetiracetam is recommended due to its favorable profile, ease of use, and lower risk of drug interactions. For women of childbearing age, levetiracetam is preferred over agents like valproic acid, which carries a high teratogenic risk. During pregnancy and lactation, levetiracetam is considered relatively safe, although folate supplementation should also be initiated to further reduce the risk of neural tube defects. Option A: Valproic acid is effective for generalized and focal seizures but is highly teratogenic and less favorable in women of reproductive age. Option B: Ethosuximide is primarily used for typical absence seizures and is not appropriate for focal seizures or seizures due to structural brain lesions. Option C: Keppra (Levetiracetam) is the best choice given its efficacy in focal seizures, favorable adverse effect profile, and safety in women of childbearing age. Option D: Topiramate is a broad-spectrum ASM but is not typically the first-line agent in the setting of a hemorrhagic lesion and may have problematic cognitive side effects. 1. Levetiracetam is often the first-line choice in patients with brain injuries and hemorrhagic lesions due to its efficacy and safety profile. 2. Avoid ASM with high teratogenic risk (e.g., valproic acid) in women of childbearing potential. 3. Recognize that focal seizures secondary to structural brain lesions may present with impaired awareness and a postictal state. Recent studies and guideline updates from the International League Against Epilepsy (ILAE) and American Academy of Neurology (AAN) highlight Levetiracetam as a first-line agent in the management of seizures associated with intracerebral hemorrhage or structural lesions. Its minimal drug-drug interactions and relatively favorable safety profile, particularly in pregnancy and lactation, have solidified its role in current clinical practice.",
    "exam_year": "2023",
    "exam_type": "Promotion"
  },
  {
    "question": "Young male with DM has gait and limb ataxia, lower limb weakness, hearing loss, examination showed lower limbs weakness and areflexia what will you do to this patient:",
    "option_a": "Send him to cardiology to rule out cardiomyopathy",
    "option_b": "most of them are Autosomal dominant",
    "option_c": "related to CAG",
    "option_d": "relate d to CTG",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-otology",
    "explanation": "The patient\u2019s presentation is highly suggestive of Friedreich\u2019s ataxia, a neurodegenerative disorder that often presents with gait and limb ataxia, lower limb weakness, diabetes mellitus, and sensorineural deficits. Friedreich\u2019s ataxia is known for its cardiac involvement, particularly hypertrophic cardiomyopathy, which is a major cause of morbidity and mortality. Friedreich\u2019s ataxia is caused by a GAA triplet repeat expansion in the FXN gene, leading to frataxin deficiency. This deficiency results in mitochondrial iron dysregulation, increased oxidative stress, and subsequent degeneration of nerve tissue as well as cardiac myocytes, which underlies the development of cardiomyopathy. Patients with Friedreich\u2019s ataxia typically present in childhood or adolescence with progressive ataxia, loss of deep tendon reflexes, dysarthria, and sometimes sensorineural hearing loss. The involvement of the heart is common, and diabetes mellitus may also occur. Hence, evaluating cardiac function is essential in these patients. The work-up includes genetic testing for the FXN gene expansion, neurological examination, and cardiac evaluation with EKG and echocardiography to assess for hypertrophic cardiomyopathy. Differential diagnoses include other spinocerebellar ataxias and mitochondrial disorders but are differentiated by genetic testing and specific clinical features. The latest guidelines recommend a multidisciplinary approach. The first step in management is to evaluate cardiac function\u2014referral to cardiology for echocardiography and follow\u2010up is critical. There is no curative treatment; management is symptomatic and supportive, including physical therapy and cardiac care (e.g., ACE inhibitors or beta blockers). In pregnancy or lactation, caution with medications is advised and care should be coordinated with maternal\u2013fetal specialists. Option A \u2013 Correct. Referral to cardiology to rule out cardiomyopathy is essential given the high incidence of cardiac involvement in Friedreich\u2019s ataxia. Option B \u2013 Incorrect because Friedreich\u2019s ataxia is autosomal recessive, not autosomal dominant. Option C \u2013 Incorrect as Friedreich\u2019s ataxia is due to a GAA repeat expansion, not a CAG repeat expansion (which is seen in disorders like Huntington's disease). Option D \u2013 Incorrect because CTG repeat expansions are associated with myotonic dystrophy, not with Friedreich\u2019s ataxia. 1. Friedreich\u2019s ataxia often presents with a combination of neurological deficits and diabetes mellitus. 2. Hypertrophic cardiomyopathy is a common and serious complication. 3. The genetic defect involves a GAA repeat expansion \u2013 not CAG or CTG. Recent studies emphasize early and regular cardiac monitoring in Friedreich\u2019s ataxia to mitigate cardiac complications. Research is also ongoing in potential gene therapies and antioxidants to manage mitochondrial dysfunction, although current practice remains supportive.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Scenario of glossopharyngeal neuralgia, what to do next?",
    "option_a": "MRI of the head and neck",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-otology",
    "explanation": "Glossopharyngeal neuralgia is a cranial neuralgia characterized by intermittent, severe, lancinating pain in the distribution of the glossopharyngeal nerve, often involving the throat, tonsillar region, and ear. The condition is thought to be due to neurovascular compression of the glossopharyngeal nerve near its root entry zone, leading to demyelination and ectopic nerve impulses. Occasionally, structural lesions or tumors must be ruled out as causes. Patients often report sudden, sharp, and stabbing pain that can be triggered by swallowing, chewing, or talking. In some cases, the pain may be accompanied by syncope or bradycardia due to vagal involvement. MRI of the head and neck is the imaging study of choice to rule out structural causes or vascular loops compressing the nerve. Differential diagnoses include trigeminal neuralgia (which involves a different nerve distribution) and other causes of throat pain like Eagle syndrome. First-line treatment typically involves anticonvulsants (e.g., carbamazepine or oxcarbazepine). MRI is mandated to exclude structural lesions. In patients who are pregnant or lactating, medication choices must be balanced with fetal/maternal risks, and non-pharmacologic interventions or surgical options should be considered after multidisciplinary consultation. Option A \u2013 Correct. An MRI of the head and neck is the appropriate next step to evaluate for vascular compression or other structural lesions. The other options are not provided, but among the available choice, Option A directly addresses the need for imaging in this scenario. 1. Glossopharyngeal neuralgia is less common than trigeminal neuralgia but can be similarly debilitating. 2. An MRI is essential to rule out compressive pathology. 3. Syncope can occur due to vagal stimulation in severe cases. Guidelines continue to support MRI as the first-line imaging modality for cranial neuralgias to exclude secondary causes. Recent case series also highlight the role of microvascular decompression for refractory cases.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Case scenario of findings suggestive of glossopharyngeal neuralgia (hints: syncope, throat pain....) asked about next?",
    "option_a": "Ent & laryngoscope",
    "option_b": "MRI brain (based on continuum)",
    "option_c": "CT head and Neck",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuro-otology",
    "explanation": "This scenario describes findings suggestive of glossopharyngeal neuralgia, with symptoms such as throat pain potentially accompanied by syncope. These symptoms warrant imaging evaluation to rule out underlying causative lesions. Similar to glossopharyngeal neuralgia in general, the disorder is often due to neurovascular compression of the glossopharyngeal nerve. This can lead to paroxysmal neuralgic pain and, in some cases, reflex-mediated syncope. The presence of syncope along with throat pain strongly suggests involvement of the glossopharyngeal nerve and possibly adjacent vagal structures. Such a presentation mandates careful evaluation using advanced imaging techniques. MRI of the brain (with specific focus on the brainstem and the cerebellopontine angle) is the most sensitive method to identify neurovascular conflicts or other structural abnormalities that could be contributing to the neuralgia. Differential diagnoses include disorders such as trigeminal neuralgia, cervical spine pathology, or even laryngeal conditions, which can be differentiated by their distinct pain patterns and imaging findings. Typical management begins with anticonvulsant medications (e.g., carbamazepine) as first-line therapy. Imaging via MRI is performed to assess for a potential vascular loop or other compressive causes. In refractory cases, surgical interventions like microvascular decompression may be considered. For pregnant or lactating patients, the use of anticonvulsants requires careful risk-benefit analysis with appropriate consultation from neurology and obstetrics. Option B \u2013 Correct. The MRI of the brain is the most suitable next step to evaluate for compressive lesions causing glossopharyngeal neuralgia. Option A (ENT & laryngoscope) is less appropriate here because the clinical picture points more towards a neuralgic pain syndrome rather than a primary ENT pathology. Option C (CT head and neck) lacks the resolution needed to assess neurovascular conflicts compared to MRI. 1. Glossopharyngeal neuralgia can present with both neuralgic pain and syncope due to vagal involvement. 2. High-resolution MRI is the gold standard imaging modality to evaluate for a vascular loop or compressive lesion. 3. Early imaging is critical in atypical presentations to rule out secondary causes. Recent research underscores the superiority of MRI over CT for detecting neurovascular conflicts in glossopharyngeal neuralgia. Updated guidelines recommend MRI as the first-line imaging study in these patients.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "question": "a man who presented with rotation vertigo that is increased when he gets out of bed or rotate his head what is the most appropriate to investigate the condition:",
    "option_a": "dix-Hallpike maneuver",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-otology",
    "explanation": "The clinical presentation described is characteristic of benign paroxysmal positional vertigo (BPPV), where vertigo is typically triggered by changes in head position. BPPV is due to the dislodgment of otoliths (calcium carbonate crystals) from the utricle into one of the semicircular canals. Their presence in the canal results in abnormal endolymph movement during head position changes, causing transient vertigo and nystagmus. Patients with BPPV experience brief episodes of spinning sensation (rotational vertigo) that are provoked by changes in head position, such as when getting out of bed or turning the head. The Dix-Hallpike maneuver is employed to reproduce these symptoms and to observe characteristic nystagmus. The Dix-Hallpike maneuver remains the gold standard bedside test to diagnose BPPV. Differential diagnoses include Meniere\u2019s disease (which presents with recurrent vertigo with auditory symptoms) and vestibular neuritis (which usually causes prolonged vertigo without positional changes). First-line treatment for BPPV is the canalith repositioning maneuvers (e.g., the Epley maneuver), which can be safely performed in most patients, including those who are pregnant or lactating. Pharmacological therapy is generally not required unless symptoms persist. In patients with contraindications to maneuvers or refractory cases, vestibular rehabilitation may be used. Option A \u2013 Correct. The Dix-Hallpike maneuver is the appropriate diagnostic test in a patient with positional vertigo, making it the correct answer. The other options are either not specified or less appropriate for this clinical scenario. 1. BPPV is the most common cause of vertigo and is often diagnosed with a simple bedside maneuver. 2. The Dix-Hallpike maneuver is both diagnostic and can help direct canalith repositioning therapy. 3. Repositioning maneuvers are first-line and effective in the vast majority of patients. Recent guidelines and studies reaffirm the efficacy of the Dix-Hallpike maneuver for diagnosing BPPV and support the use of canalith repositioning procedures as the cornerstone of treatment. These maneuvers have also been shown to be safe during pregnancy.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "a man who developed acute vertigo and dysphagia along with right side ataxia on examination the following was also found (picture of uvula deviated to left) what is the most common finding:",
    "option_a": "right ptosis",
    "option_b": "left facial hemianesthesia",
    "option_c": "left dysmetria",
    "option_d": "right up going planter",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-otology",
    "explanation": "This question describes a classic brainstem stroke syndrome \u2013 lateral medullary syndrome (Wallenberg syndrome) \u2013 which typically presents with acute vertigo, dysphagia, and ataxia. Involvement of cranial nerve nuclei (especially the nucleus ambiguus) and nearby pathways results in features such as uvula deviation and signs of Horner syndrome. Wallenberg syndrome usually results from an infarct in the lateral medulla, most commonly due to occlusion of the posterior inferior cerebellar artery (PICA). The lesion affects structures including the vestibular nuclei (producing vertigo), nucleus ambiguus (leading to dysphagia), the inferior cerebellar peduncle (causing ataxia), and the descending sympathetic fibers (resulting in ipsilateral Horner syndrome, which includes ptosis). In the patient described, acute vertigo, dysphagia, and right-sided ataxia point to a lateral medullary lesion likely on the right side. The uvula deviating to the left further confirms that the lesion affects the right nucleus ambiguus. Among the findings listed, the presence of right ptosis\u2014indicative of ipsilateral Horner syndrome\u2014is the most common associated feature. Diagnosis is primarily clinical and supported by neuroimaging. MRI with diffusion\u2010weighted imaging is the gold standard to detect the posterior circulation infarct, and CT angiography may be used to assess vascular anatomy. The differential considerations include lateral pontine syndrome and medial medullary syndrome, which are distinguished by the involvement of different cranial nerve nuclei and tracts. Acute management follows stroke protocols including reperfusion strategies when appropriate, antiplatelet therapy, and supportive care. Risk factor reduction and rehabilitation are also important. In pregnant or lactating women, imaging decisions and thrombolysis require careful risk\u2013benefit analysis with attention to fetal and neonatal safety. Medication selections should be adjusted to minimize potential teratogenic risks. \u2022 Option A (right ptosis): Correct \u2013 It represents a component of ipsilateral Horner syndrome typical of lateral medullary syndrome.  \u2022 Option B (left facial hemianesthesia): Incorrect \u2013 Sensory loss in the face, if present, is typically ipsilateral (right-sided) due to involvement of the spinal trigeminal nucleus.  \u2022 Option C (left dysmetria): Incorrect \u2013 Cerebellar signs such as dysmetria occur ipsilaterally; in a right-sided lesion, right dysmetria would be expected.  \u2022 Option D (right up going plantar): Incorrect \u2013 An upgoing plantar response indicates corticospinal tract involvement, which is not a feature of lateral medullary syndrome.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Scenario of young male with central vision loss in rt.eye then month apart let central eye vision loss then develop hearing loss, diagnosis:",
    "option_a": "Susac",
    "option_b": "Leber",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-otology",
    "explanation": "Susac syndrome is a rare autoimmune microangiopathy characterized by a clinical triad \u2013 branch retinal artery occlusions leading to visual deficits, sensorineural hearing loss, and encephalopathy. Although it is more common in young women, it can also present in males. The scenario of sequential central visual loss followed by hearing loss fits within this syndrome\u2019s spectrum. In Susac syndrome, an autoimmune\u2010mediated endotheliopathy leads to microvascular occlusions of the precapillary arterioles in the retina, brain, and cochlea. The retinal occlusions may cause infarctions that manifest as central visual deficits if the foveal circulation is involved, while the cochlear involvement produces sensorineural hearing loss. Patients with Susac syndrome may initially present with visual disturbances\u2014often due to branch retinal artery occlusions observed on fluorescein angiography\u2014and subsequently develop sensorineural hearing loss. Although encephalopathy is part of the classical triad, even in its absence the combination of bilateral sequential vision loss and hearing impairment strongly suggests the diagnosis. This helps differentiate it from other conditions like Leber\u2019s hereditary optic neuropathy which typically presents with sequential vision loss in young males but lacks significant auditory involvement. The diagnosis requires a high index of suspicion. Key tests include: (1) Fluorescein angiography to reveal branch retinal artery occlusions; (2) Brain MRI, which may show characteristic lesions in the corpus callosum; and (3) Audiometry to assess sensorineural hearing loss. Differential diagnoses include Leber\u2019s hereditary optic neuropathy (presents with central vision loss but no hearing loss) and demyelinating disorders. Management involves prompt initiation of immunosuppressive therapy to prevent irreversible end-organ damage. High-dose corticosteroids are the frontline therapy, potentially combined with IVIG or other immunomodulatory agents. In pregnancy and lactation, corticosteroids (using the lowest effective dose) are generally considered relatively safe, whereas the safety profiles of other immunosuppressive agents require careful risk\u2013benefit analysis and consultation with maternal\u2013fetal medicine specialists. Option A (Susac syndrome) is appropriate because it explains the association of sequential bilateral central vision loss (via retinal branch occlusions) with hearing loss. Option B (Leber hereditary optic neuropathy) is less likely because although it presents with sequential central vision loss in young males, it does not characteristically cause hearing loss. Options C and D are not provided, so they do not contribute to the decision-making process. \u2022 Sequential central vision loss in a young patient should prompt consideration of both LHON and Susac syndrome. \u2022 The presence of sensorineural hearing loss is a key indicator favoring Susac syndrome even in a young male. \u2022 Fluorescein angiography and brain MRI are critical in supporting the diagnosis. Recent literature supports early aggressive immunosuppressive treatment in Susac syndrome to avoid permanent neurological sequelae. Current clinical guidelines also emphasize the importance of tailoring immunosuppressive therapy during pregnancy and lactation, highlighting the relative safety of corticosteroids in these populations while urging caution with other agents.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Patient came with ataxia and optic atrophy, hearing loss, and slow saccades; what is the Dx?",
    "option_a": "Macchado joseph",
    "option_b": "SCA 6",
    "option_c": "SCA 7",
    "option_d": "NARP",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Neuro-otology",
    "explanation": "Spinocerebellar ataxia type 7 (SCA7) is an autosomal dominant neurodegenerative disorder marked by progressive cerebellar ataxia combined with visual impairment. The visual loss results from retinal degeneration that eventually leads to optic atrophy. Ocular motor abnormalities, including slow saccades, are also characteristic, which aligns closely with the presenting symptoms. SCA7 is caused by a CAG trinucleotide repeat expansion in the ATXN7 gene. This abnormal expansion results in the production of a mutant ataxin-7 protein with an elongated polyglutamine tract that misfolds and aggregates. The ensuing toxic gain\u2010of\u2010function leads to neuronal degeneration in the cerebellum, brainstem (affecting saccades), and retina (resulting in degeneration of photoreceptors and retinal pigment epithelium, clinically manifesting as optic atrophy). The patient presents with ataxia, optic atrophy, hearing loss, and slow saccades. While hearing loss is not the most emphasized feature of SCA7, ocular motor dysfunction and retinal degeneration (manifesting as optic atrophy) together with cerebellar ataxia strongly indicate SCA7. Other SCAs (like SCA3 or SCA6) and mitochondrial disorders (such as NARP) may cause ataxia and ocular findings, but the specific combination here best fits SCA7. Diagnosis is based on clinical evaluation and neuro-ophthalmological examination along with neuroimaging. Definitive diagnosis is achieved through genetic testing confirming the CAG repeat expansion in ATXN7. Differential diagnosis should consider other spinocerebellar ataxias (e.g., SCA3/Machado-Joseph disease, SCA6) and mitochondrial conditions like NARP, but the pattern of retinal involvement with optic atrophy and slow saccades is most consistent with SCA7. There is no disease\u2010modifying treatment for SCA7; management remains symptomatic and supportive. This includes physical therapy, occupational therapy, speech therapy, and adaptive devices to assist with visual impairment. Genetic counseling is critical, especially for patients of child-bearing age. In pregnancy and lactation, counseling should address the risks of transmission, discuss options such as preimplantation genetic diagnosis, and emphasize a multidisciplinary care approach. Routine supportive care continues during lactation with no specific contraindications or required alterations. Option A (Machado-Joseph disease or SCA3) often presents with ataxia and ophthalmoplegia but typically lacks the marked retinal degeneration seen in SCA7. Option B (SCA6) generally presents as pure cerebellar ataxia with minimal extra-cerebellar features. Option D (NARP) is a mitochondrial disorder that usually presents with retinitis pigmentosa rather than frank optic atrophy and lacks the classic slow saccades seen in SCA7. Therefore, Option C (SCA7) best conforms to the clinical picture provided. SCA7 is the only spinocerebellar ataxia that prominently features retinal degeneration leading to severe visual impairment. Early recognition through genetic testing is essential for management. Genetic counseling regarding reproductive risks is also paramount. Recent research is focused on unraveling the molecular mechanisms behind polyglutamine toxicity in SCA7 and exploring potential gene-targeted therapies such as RNA interference and gene-silencing strategies. However, current clinical management remains supportive.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "Glossopharyngeal neuralgia treatment",
    "option_a": "CBZ",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-otology",
    "explanation": "Glossopharyngeal neuralgia is a neuropathic pain syndrome characterized by paroxysmal, sharp, and stabbing pain in the distribution of the glossopharyngeal nerve, including the oropharynx and ear. It shares similarities with trigeminal neuralgia and is often triggered by swallowing, chewing, or speaking. The condition is thought to be primarily due to neurovascular compression at the nerve\u2019s root entry zone resulting in focal demyelination. This leads to abnormal or \u2018ephaptic\u2019 transmission of nerve signals, generating paroxysmal pain episodes. Patients typically present with sudden, severe, and lancinating pain in the throat, posterior tongue, tonsillar region, and sometimes radiating into the ear. The pain is usually brief, recurrent, and can be triggered by activities such as swallowing or talking. Diagnosis is largely clinical based on detailed history and physical examination. Differential diagnoses include trigeminal neuralgia, temporomandibular joint disorders, and other causes of throat pain. Neuroimaging, especially MRI, may be used to rule out structural lesions like tumors or vascular compressions. Carbamazepine (CBZ) is the first-line treatment for glossopharyngeal neuralgia. It works by stabilizing hyperexcitable neuronal membranes and reducing abnormal nerve firing. Current guidelines recommend titrating the dose carefully while monitoring for side effects. In cases where patients are pregnant or lactating, careful consideration is required: for pregnant patients, carbamazepine has potential teratogenic effects (notably neural tube defects) particularly during the first trimester, so alternative management or increased surveillance is advisable; during lactation, while CBZ does pass into breast milk, infants should be monitored for adverse effects. Other treatment modalities, including second-line anticonvulsants and surgical interventions (e.g., microvascular decompression), may be considered in refractory cases. Option A (CBZ) is the only option provided and is indeed the first-line pharmacologic treatment for glossopharyngeal neuralgia. While other options might include medications such as oxcarbazepine or surgical management, the evidence supports CBZ as the standard initial therapy. Recognize the overlap in treatment strategy between glossopharyngeal and trigeminal neuralgia. When managing women who are pregnant or breastfeeding, always weigh the benefits of CBZ against its potential risks and consider alternative therapies or additional monitoring if necessary. Recent clinical guidelines and systematic reviews confirm carbamazepine\u2019s efficacy as the frontline treatment for glossopharyngeal neuralgia, with a well-documented benefit-risk profile. Continued research and clinical updates support its use, with attention to special population considerations including those who are pregnant or lactating.",
    "exam_year": "2023",
    "exam_type": "Part II"
  },
  {
    "question": "A patient with history of back of throat pain and tongue pain with episodic syncope, what\u2019s your next step:",
    "option_a": "Refer to ENT for laryngoscope",
    "option_b": "MRI brain",
    "option_c": "EEG with photic stimulation",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuroanatomy",
    "explanation": "Glossopharyngeal neuralgia is a rare cranial neuralgia characterized by paroxysms of severe, shooting pain in the distribution of the glossopharyngeal nerve \u2013 including the back of the throat, base of the tongue, and sometimes the ear. The presence of episodic syncope suggests an exaggerated vagal reflex accompanying the neuralgic pain. This condition is thought to result from neurovascular compression at the root entry zone of the glossopharyngeal nerve, leading to aberrant pain signaling. The close anatomical and functional relationship between the glossopharyngeal and vagus nerves can trigger episodic bradycardia or even transient asystole, resulting in syncope. High-resolution MRI is used to evaluate possible compressive lesions or vascular loops responsible for the nerve irritation. Patients typically experience sudden, lancinating pain in the throat and tongue, often triggered by swallowing, chewing, or even talking. The associated syncope is a result of vagal overactivity secondary to the pain. These clinical features help differentiate it from other causes of oropharyngeal pain and syncopal events such as cardiac arrhythmias or epileptic phenomena. The work-up includes ruling out structural lesions or vascular anomalies with high-resolution MRI brain imaging. Differential diagnosis includes cardiac causes of syncope, seizure disorders (which might necessitate an EEG), and local ENT pathologies. Given the neuralgic pain with syncope, neuroimaging is warranted before further intervention. Initial treatment typically involves medical management with anticonvulsants such as carbamazepine. If the pain is refractory, surgical interventions like microvascular decompression may be considered. Special considerations in pregnancy and lactation include caution with medications like carbamazepine due to potential teratogenic risks; dose adjustments and multidisciplinary management are required in such populations. Option A (Refer to ENT for laryngoscope) would be more appropriate for primary laryngeal or voice disorders, not neuralgia. Option B (MRI brain) is the correct next step as it facilitates identification of any neurovascular compression or structural lesion causing the neuralgia. Option C (EEG with photic stimulation) is used to evaluate seizures and does not match this clinical presentation. 1. Glossopharyngeal neuralgia may produce syncope due to vagal overactivity triggered by severe pain. 2. High-resolution MRI is the imaging modality of choice to evaluate for neurovascular compression. 3. A thorough history is key to distinguishing neuralgic pain from other causes of throat discomfort. Recent guidelines and studies emphasize early neuroimaging with MRI in suspected cranial neuralgias to exclude compressive lesions, aligning with the rationale for using MRI in this scenario. Advances in neurosurgical techniques for microvascular decompression further support early identification of the underlying cause.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "What resembles thalamus aphasia:",
    "option_a": "Transcortical sensory",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuroanatomy",
    "explanation": "Aphasia is a disorder of language that can be classified based on fluency, comprehension, repetition, and naming abilities. Thalamic aphasia is a rare, subcortical form of aphasia that shares similarities with transcortical sensory aphasia. Lesions in the thalamus disrupt normal language networks due to its extensive connections with cortical areas. The pattern of deficits\u2014in particular, fluent speech with impaired comprehension but preserved repetition\u2014is strikingly similar to what is seen in transcortical sensory aphasia, where the primary language areas remain intact while associative areas are affected. Patients with thalamic aphasia often present with fluent, sometimes evasive speech, impaired auditory comprehension, and relatively preserved repetition. These characteristics closely mirror those seen in transcortical sensory aphasia, which assists clinicians in differentiating between aphasia types in stroke or other neurological insults. Differentiating thalamic aphasia from other types involves comprehensive language testing. Key differentials include Wernicke\u2019s aphasia (fluent with poor comprehension and impaired repetition) and conduction aphasia (fluent speech with marked repetition deficits). Detailed neuropsychological evaluations and neuroimaging (MRI) help localize the lesion and clarify the diagnosis. Management primarily involves speech and language therapy. In cases related to vascular events, addressing risk factors such as hypertension is important. When managing aphasia in pregnant or lactating patients, non-pharmacologic interventions like intensive speech therapy are preferred to avoid risks associated with medications. Option A (Transcortical sensory) is correct because both thalamic aphasia and transcortical sensory aphasia share the hallmark features of fluent speech, preserved repetition, and impaired comprehension. Other unlisted options would not mimic this specific profile if they were related to, for example, Broca\u2019s (nonfluent) or Wernicke\u2019s (repetition impaired) aphasias. 1. Thalamic aphasia presents with fluent speech, impaired comprehension, yet preserved repetition\u2014this is the core similarity shared with transcortical sensory aphasia. 2. Detailed language and cognitive assessments are essential in accurately classifying aphasia types. 3. The thalamus plays a larger role in language processing than previously thought. Recent neuroimaging and neuropsychological studies have highlighted the involvement of subcortical structures like the thalamus in complex language processing, thereby reinforcing the clinical overlap between thalamic and transcortical sensory aphasia.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Nerve supply to sartorius muscle:",
    "option_a": "femoral",
    "option_b": "obturator",
    "option_c": "genitofemoral",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuroanatomy",
    "explanation": "The sartorius is the longest muscle in the human body, located in the anterior compartment of the thigh. Its function in leg flexion, abduction, and external rotation is controlled by its innervation, which is essential for coordinated movement. The femoral nerve, which arises from the lumbar plexus (primarily L2-L4), innervates the sartorius muscle. This nerve is responsible for motor function across the anterior thigh. Injury to the femoral nerve can lead to weakness or impaired control in the muscles it supplies. Clinically, an injury to the femoral nerve might present as weakness in hip flexion and knee extension, along with diminished sensation in the anterior thigh and medial leg. Recognizing the nerve supply is critical in diagnosing nerve injuries and planning rehabilitation. Differential diagnoses include nerve entrapment syndromes such as meralgia paresthetica (lateral femoral cutaneous nerve) or obturator nerve injuries affecting the medial thigh. Electromyography (EMG) and nerve conduction studies can help differentiate these conditions. Management of a femoral nerve injury often begins with conservative treatments including rest, physical therapy, and pain management. In cases of severe nerve damage, surgical evaluation may be warranted. In pregnant or lactating patients, conservative management is emphasized to avoid risks associated with invasive procedures or neurotoxic medications. Option A (Femoral nerve) is correct because it is the primary nerve supply to the sartorius muscle. Option B (Obturator nerve) supplies the medial thigh muscles, and Option C (Genitofemoral nerve) primarily supplies the skin over the upper thigh and groin, not the sartorius. 1. The sartorius muscle is exclusively innervated by the femoral nerve. 2. Knowledge of the nerve supply is crucial for diagnosing and managing thigh injuries. 3. Femoral nerve function is critical for coordinating anterior thigh muscle activity. Anatomical and clinical studies continue to reinforce that the femoral nerve is responsible for innervating the sartorius muscle. This foundational knowledge remains unchanged and is regularly referenced in modern clinical practice and surgical anatomy texts.",
    "exam_year": "2020",
    "exam_type": "Part II"
  }
]